A Study to Understand About the Study Medicine Palbociclib in Breast Cancer Patients After it is Out in the Japanese Market

NCT07096024 · clinicaltrials.gov ↗

COMPLETED

Status

1772

Enrollment

INDUSTRY

Sponsor class

Conditions

Breast Neoplasms

Interventions

DRUG: palbociclib plus fulvestrant
DRUG: fulvestrant

Sponsor

Pfizer